RxDoctor Payments Data

Tessa Offerle

Nurse Practitioner · Fort Wayne, INNPI 1558031971

Payments from drug & device makers

$929in general payments, 2019–2025

Across 34 payments — averaging $27.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$305
  • Boston Scientific$130
  • Boehringer Ingelheim$105
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$95
  • Merck$56
  • Johnson & Johnson$44
  • plus $194 from 9 others

What the payments were for

  • Food & beverage$929100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$929 in reported general payments places this provider in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$20,297
Medicare patients
180
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan104$149,166
EliquisApixaban99$126,021
JardianceEmpagliflozin74$86,648
Torsemide104$2,908
Potassium Chloride20$2,819
Metoprolol Succinate153$1,651
Spironolactone157$1,033
Isosorbide Dinitrate16$895
Carvedilol103$784
Atorvastatin Calcium94$546
Furosemide108$532
Losartan Potassium46$455
Nitroglycerin23$426
Klor-Con M20Potassium Chloride18$396
Amiodarone Hcl26$389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$126,02199 claims
Boehringer IngelheimJardiance$105$86,64874 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →